ARIC RA-SEAN RAY

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family SIERRA VISTA, AZ NPI 1245843465

General Payments — all program years on this page

$485.73

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 30
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $303.67 across 18 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $303.6718

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $36.593
2022 $15.681
2023 $129.798
2024 $303.6718

Records — PY2024 (18)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1104337140 AstraZeneca Pharmaceuticals LP $15.32 04/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105262758 AstraZeneca Pharmaceuticals LP $17.60 04/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105852934 AstraZeneca Pharmaceuticals LP $13.60 08/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108063899 ABBVIE INC. $21.01 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114549697 Exact Sciences Corporation $15.25 10/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141801464 Merck Sharp & Dohme LLC $25.12 06/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151199249 Phathom Pharmaceuticals, Inc. $19.15 04/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151199251 Phathom Pharmaceuticals, Inc. $15.04 05/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151199253 Phathom Pharmaceuticals, Inc. $17.16 07/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151199255 Phathom Pharmaceuticals, Inc. $21.43 09/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151199257 Phathom Pharmaceuticals, Inc. $14.91 10/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153435873 Salix Pharmaceuticals, a division of Bausch Health US, LLC $15.18 12/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153582391 Salix Pharmaceuticals, a division of Bausch Health US, LLC $15.97 06/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153642558 Salix Pharmaceuticals, a division of Bausch Health US, LLC $15.06 06/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153672643 Salix Pharmaceuticals, a division of Bausch Health US, LLC $16.12 03/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153713827 Salix Pharmaceuticals, a division of Bausch Health US, LLC $15.18 07/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153714613 Salix Pharmaceuticals, a division of Bausch Health US, LLC $16.77 05/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153714938 Salix Pharmaceuticals, a division of Bausch Health US, LLC $13.80 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.